These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5011863)

  • 21. [Experimental and clinical studies on effects of glucagon on the ischmic heart].
    Asai Y
    Nihon Kyobu Geka Gakkai Zasshi; 1974 Dec; 22(12):1158-71. PubMed ID: 4477168
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular effects of glucagon in man.
    Parmley WW; Glick G; Sonnenblick EH
    N Engl J Med; 1968 Jul; 279(1):12-7. PubMed ID: 4872564
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glucagon and its importance in clinical practice].
    Anisimov VE
    Klin Med (Mosk); 1974 Jul; 52(7):12-8. PubMed ID: 4603563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of glucagon on carbohydrate metabolism in the isolated rat heart].
    Gmeiner R; Brachfeld N
    Arch Kreislaufforsch; 1971; 65(3):151-61. PubMed ID: 5136845
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of glucagon.
    Forester D
    Am Heart J; 1979 Apr; 97(4):545-6. PubMed ID: 425893
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucagon: hormone or therapeutic agent?
    Hall-Boyer K; Zaloga GP; Chernow B
    Crit Care Med; 1984 Jul; 12(7):584-9. PubMed ID: 6375966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cardiological use of glucagon-zinc-protamine in diabetes].
    Bruni B
    Minerva Med; 1972 Nov; 63(83):4513-9. PubMed ID: 4404792
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of glucagon on dogs with acute and chronic heart block.
    Hurwitz RA
    Am Heart J; 1971 May; 81(5):644-9. PubMed ID: 5552067
    [No Abstract]   [Full Text] [Related]  

  • 29. The unique cardiotonic properties of glucagon.
    Timmis GC; Ramos RG; Parikh R; Henke J; Gordon S
    Mich Med; 1973 May; 72(15):353-7. PubMed ID: 4700128
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiotonic effects of glucagon].
    Robert M; Humair L
    Schweiz Med Wochenschr; 1970 Aug; 100(31):1345-52. PubMed ID: 5513359
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glucagon in the treatment of shock].
    Kedrowa S
    Pol Tyg Lek; 1976 Mar; 31(12):487-9. PubMed ID: 1272935
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
    Kones RJ
    Angiology; 1974 May; 25(5):317-33. PubMed ID: 4150913
    [No Abstract]   [Full Text] [Related]  

  • 33. [Action of glucagon on the cardiovascular system and its possible use in cardiological therapy].
    Sgarbi M; Vaona P; Neri M
    Minerva Cardioangiol; 1974 Jun; 22(6):481-9. PubMed ID: 4847337
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of glucagon on calcium exchangeability, coronary blood flow, myocardial function and high energy phosphate stores.
    Nayler WG; McInnes I; Chipperfield D; Carson V; Daile P
    J Pharmacol Exp Ther; 1970 Feb; 171(2):265-75. PubMed ID: 5459062
    [No Abstract]   [Full Text] [Related]  

  • 35. The biological significance of the insulinotropic effect of glucagon in man.
    Marks V
    Acta Isot (Padova); 1970; 10(3):219-27. PubMed ID: 4946331
    [No Abstract]   [Full Text] [Related]  

  • 36. Rational therapeutic approach to cardiogenic shock.
    Wiener L
    Cardiovasc Clin; 1974; 6(2):223-37. PubMed ID: 4613459
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolic effects of glucagon in obesity in children (a review of the literature)].
    Smirnova GI
    Vopr Okhr Materin Det; 1978 Jul; 23(7):33-7. PubMed ID: 210592
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucagon: present status in cardiovascular disease.
    Kones RJ; Phillips JH
    Clin Pharmacol Ther; 1971; 12(3):427-44. PubMed ID: 4936033
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of glucagon on regional blood flow during cardiogenic shock.
    Sivarajan M; Amory DW
    Circ Shock; 1979; 6(4):365-73. PubMed ID: 119586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of glucagon in the treatment of severe contractile insufficiency of the myocardium].
    Bertolazzi R; Ricciardi S; Marenco G
    Minerva Med; 1976 Nov; 67(54):3519-24. PubMed ID: 995299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.